A cluster randomized trial to evaluate physician/pharmacist collaboration to improve blood pressure control

Journal of Clinical Hypertension

Volumn 10, Issue 4, 2008, Pages 260-271

  Carter, Barry L ^a,b   Bergus, George R ^b   Dawson, Jeffrey D ^a   Farris, Karen B ^a   Doucette, William R ^a   Chrischilles, Elizabeth A ^a   Hartz, Arthur J ^b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CLINICAL TRIAL; CLUSTER ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COOPERATION; EDUCATION; FEMALE; HUMAN; HYPERTENSION; MALE; MIDDLE AGED; PATIENT CARE; PHARMACIST; PHYSICIAN; PROSPECTIVE STUDY; PUBLIC RELATIONS; RANDOMIZED CONTROLLED TRIAL; SYSTOLE;

ADULT; AGED; AGED, 80 AND OVER; BLOOD PRESSURE; CLUSTER ANALYSIS; COOPERATIVE BEHAVIOR; EDUCATIONAL MEASUREMENT; FEMALE; HUMANS; HYPERTENSION; INTERPROFESSIONAL RELATIONS; MALE; MIDDLE AGED; PATIENT CARE TEAM; PHARMACISTS; PHYSICIANS; PROSPECTIVE STUDIES; SYSTOLE;

EID: 45749149439     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/j.1751-7176.2008.07434.x     Document Type: Article

References (47)

1. European Society of Hypertension-European Society ofCardiology Guidelines Committee. 2003 European Societyof Hypertension-European Society of Cardiology guidelinesfor the management of arterial hypertension. J Hypertens.2003;21(6):1011-1053
2. World Health Organization. World Health Report2002-Reducing Risks, Promoting Healthy Life. Geneva,Switzerland: World Health Organization; 2002. http://www.who.int/whr/2002/. Accessed December 26, 2006
3. Seventh Report of the Joint National Committee onPrevention, Detection, Evaluation, and Treatment of HighBlood Pressure. Hypertension. 2003;42(6):1206-1252
4. Garg JP, Elliott WJ, Folker A, et al. Resistant hypertensionrevisited: a comparison of two university-based cohorts.Am J Hypertens. 2005;18(5, pt 1):619-626
5. Berlowitz DR, Ash AS, Hickey EC, et al. Inadequate managementof blood pressure in a hypertensive population. NEngl J Med. 1998;339(27):1957-1963
6. Oliveria SA, Lapuerta P, McCarthy BD, et al. Physicianrelatedbarriers to the effective management of uncontrolledhypertension. Arch Intern Med. 2002;162(4):413-420
7. Hyman DJ, Pavlik VN. Characteristics of patients withuncontrolled hypertension in the United States. N Engl JMed. 2001;345(7):479-486
8. Milchak JL, Carter BL, James PA , et al. Measuring adherenceto practice guidelines for the management of hypertension:an evaluation of the literature. Hypertension.2004;44(5):602-608
9. Carter BL, Malone DC, Ellis SL, et al. Antihypertensivedrug utilization in hypertensive veterans with complexmedication profiles. J Clin Hypertens (Greenwich).2000;2(3):172-180
10. Hill MN, Levine DM, Whelton PK. Awareness, use, andimpact of the 1984 Joint National Committee consensusreport on high blood pressure. Am J Public Health.1988;78(9):1190-1194
11. Naiman DJ, Barker LR. Adherence to the JNC VI guidelinesfor the treatment of hypertension in the resident clinic.Md Med J. 1999;48(6):307-311
12. Nelson CR, Knapp DA. Trends in antihypertensivedrug therapy of ambulatory patients by US office-basedphysicians. Hypertension. 2000;36(4):600-603
13. Ong KL, Cheung BM, Man YB, et al. Prevalence, awareness,treatment, and control of hypertension among United Statesadults 1999-2004. Hypertension. 2007;49(1):69-75
14. Goldstein MK, Lavori P, Coleman R, et al. Improvingadherence to guidelines for hypertension drug prescribing:cluster-randomized controlled trial of general versuspatient-specific recommendations. Am J Manag Care.2005;11(11):677-685
15. Walsh JM, McDonald KM, Shojania KG, et al. Qualityimprovement strategies for hypertension management: asystematic review. Med Care. 2006;44(7):646-657
16. Lee JK, Grace KA, Taylor AJ. Effect of a pharmacy care programon medication adherence and persistence, blood pressure,and low-density lipoprotein cholesterol: a randomizedcontrolled trial. JAMA. 2006;296(21):2563-2571
17. Carter BL, Hartz A, Bergus G, et al. Relationship betweenphysician knowledge of hypertension and blood pressure control.J Clin Hypertens (Greenwich). 2006;8(7):481-486
18. Grol R, Grimshaw J. From best evidence to best practice:effective implementation of change in patients' care.Lancet. 2003;362(9391):1225-1230
19. Battersby MW. Health reform through coordinated care:SA HealthPlus. BMJ. 2005;330(7492):662-665
20. Wilson T, Buck D, Ham C. Rising to the challenge: willthe NHS support people with long term conditions? BMJ.2005;330(7492):657-661
21. Avery AJ, Pringle M. Extended prescribing by UK nursesand pharmacists. BMJ. 2005;331(7526):1154-1155
22. Carter BL, Zillich AJ, Elliott WJ. How pharmacists canassist physicians with controlling blood pressure. J ClinHypertens (Greenwich). 2003;5(1):31-37
23. Bogden PE, Abbott RD, Williamson P, et al. Comparingstandard care with a physician and pharmacist teamapproach for uncontrolled hypertension. J Gen Intern Med.1998;13(11):740-745
24. Bond CA, Monson R. Sustained improvement in drugdocumentation, compliance, and disease control. A fouryearanalysis of an ambulatory care model. Arch InternMed. 1984;144(6):1159-1162
25. Borenstein JE, Graber G, Saltiel E, et al. Physicianpharmacistcomanagement of hypertension: a randomized,comparative trial. Pharmacotherapy. 2003;23(2):209-216
26. Bogden PE, Koontz LM, Williamson P, et al. The physicianand pharmacist team. An effective approach to cholesterolreduction. J Gen Intern Med. 1997;12(3):158-164
27. Carter BL, Barnette DJ, Chrischilles E, et al. Evaluationof hypertensive patients after care provided by communitypharmacists in a rural setting. Pharmacotherapy.1997;17(6):1274-1285
28. Erickson SR , Slaughter R, Halapy H. Pharmacists'ability to influence outcomes of hypertension therapy.Pharmacotherapy. 1997;17(1):140-147
29. Hawkins DW, Fiedler FP, Douglas HL, et al. Evaluation ofa clinical pharmacist in caring for hypertensive and diabeticpatients. Am J Hosp Pharm. 1979;36(10):1321-1325
30. Kaboli PJ, Hoth A, Carter BL, et al. The VA EnhancedPharmacy Outpatient Clinic (EPOC) Study: a randomized-controlled pharmacist-physician intervention trial[abstract]. J Gen Intern Med. 2004;19(suppl 1):227
31. Wright JT Jr, Bakris G, Greene T, et al. Effect of blood pressurelowering and antihypertensive drug class on progressionof hypertensive kidney disease: results from the AASKtrial. JAMA. 2002;288(19):2421-2431
32. Pickering TG, Hall JE, Appel LJ, et al. Recommendationsfor blood pressure measurement in humans and experimentalanimals: part 1: blood pressure measurement in humans:a statement for professionals from the Subcommittee ofProfessional and Public Education of the American HeartAssociation Council on High Blood Pressure Research.Hypertension. 2005;45(1):142-161
33. Ǒbrien E, Coats A, Owens P, et al. Use and interpretationof ambulatory blood pressure monitoring:recommendations of the British hypertension society. BMJ.2000;320(7242):1128-1134
34. Farris KB, Cote I, Feeny D, et al. Enhancing primary carefor complex patients. Demonstration project using multidisciplinaryteams. Can Fam Physician. 2004;50:998-1003
35. Julius S, Kjeldsen SE, Weber M, et al. Outcomes in hypertensivepatients at high cardiovascular risk treated withregimens based on valsartan or amlodipine: the VALUErandomised trial. Lancet. 2004;363(9426):2022-2031
36. Carter BL, Frohlich ED, Elliott WJ, et al. Selected factorsthat influence responses to antihypertensives. Choosingtherapy for the uncomplicated patient. Arch Fam Med.1994;3(6):528-536
37. Moser M, Franklin SS. Hypertension management: resultsof a new national survey for the hypertension educationfoundation: Harris interactive. J Clin Hypertens(Greenwich). 2007;9(5):316-323
38. Moser M, Setaro JF. Clinical practice. Resistant ordifficult-to-control hypertension. N Engl J Med.2006;355(4):385-392
39. Singer GM, Izhar M, Black HR. Goal-oriented hypertensionmanagement: translating clinical trials to practice.Hypertension. 2002;40(4):464-469
40. Neaton JD, Grimm RH Jr, Prineas RJ, et al. Treatmentof Mild Hypertension Study. Final results. Treatmentof Mild Hypertension Study Research Group. JAMA.1993;270(6):713-724.
41. Materson BJ, Reda DJ, Cushman WC, et al. Single-drugtherapy for hypertension in men. A comparison of six antihypertensiveagents with placebo. The Department of VeteransAffairs Cooperative Study Group on AntihypertensiveAgents. N Engl J Med. 1993;328(13):914-921
42. Caro JJ, Salas M, Speckman JL, et al. Persistence withtreatment for hypertension in actual practice. CMAJ.1999;160(1):31-37.
43. Billups SJ, Malone DC, Carter BL. The relationshipbetween drug therapy noncompliance and patient characteristics,health-related quality of life, and health care costs.Pharmacotherapy. 2000;20(8):941-949
44. Villegas I, Arias IC, Botero A, et al. Evaluation of thetechnique used by health-care workers for taking bloodpressure. Hypertension. 1995;26(6, pt 2):1204-1206
45. Rothman R, Weinberger M. The role of pharmacists inclinical care: where do we go from here? Eff Clin Pract.2002;5(2):91-94.==46 The ALLHAT Officers and Coordinators for the ALLHATCollaborative Research Group. Major outcomes in highriskhypertensive patients randomized to angiotensinconvertingenzyme inhibitor or calcium channel blockervs diuretic: the Antihypertensive and Lipid-LoweringTreatment to Prevent Heart Attack Trial (ALL HAT).JAMA. 2002;288(23):2981-2997
46. The ALLHAT Officers and Coordinators for the ALLHATCollaborative Research Group. Major outcomes in highriskhypertensive patients randomized to angiotensinconvertingenzyme inhibitor or calcium channel blockervs diuretic: the Antihypertensive and Lipid-LoweringTreatment to Prevent Heart Attack Trial (ALL HAT).JAMA. 2002;288(23):2981-2997
47. VA/DoD Clinical Practice Guideline for Diagnosis andManagement of Hypertension in the Primary Care Setting.Washington, DC: Department of Veterans Administration,Department of Defense; 2004. Revised July 2005